The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No CSPEC related information was provided by the message!

  • See Evidence submitted by expert panel for details.

Variant: NM_000527.5(LDLR):c.1765G>A (p.Asp589Asn)

CA036508

252022 (ClinVar)

Gene: LDLR
Condition: hypercholesterolemia, familial
Inheritance Mode: Semidominant inheritance
UUID: fd0cb6c9-7f1e-4644-9c34-95083a79a553
Approved on: 2022-08-29
Published on: 2022-12-23

HGVS expressions

NM_000527.5:c.1765G>A
NM_000527.5(LDLR):c.1765G>A (p.Asp589Asn)
NC_000019.10:g.11116918G>A
CM000681.2:g.11116918G>A
NC_000019.9:g.11227594G>A
CM000681.1:g.11227594G>A
NC_000019.8:g.11088594G>A
NG_009060.1:g.32538G>A
ENST00000558518.6:c.1765G>A
ENST00000252444.9:n.2019G>A
ENST00000455727.6:c.1261G>A
ENST00000535915.5:c.1642G>A
ENST00000545707.5:c.1384G>A
ENST00000557933.5:c.1765G>A
ENST00000558013.5:c.1765G>A
ENST00000558518.5:c.1765G>A
ENST00000559340.1:n.426+706G>A
NM_000527.4:c.1765G>A
NM_001195798.1:c.1765G>A
NM_001195799.1:c.1642G>A
NM_001195800.1:c.1261G>A
NM_001195803.1:c.1384G>A
NM_001195798.2:c.1765G>A
NM_001195799.2:c.1642G>A
NM_001195800.2:c.1261G>A
NM_001195803.2:c.1384G>A

Uncertain Significance

Met criteria codes 1
BP4
Not Met criteria codes 4
BP5 PM2 PM5 PS4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Familial Hypercholesterolemia VCEP
The NM_000527.5(LDLR):c.1765G>A (p.Asp589Asn) variant is classified as Uncertain significance - insufficient evidence for Familial Hypercholesterolemia by applying evidence codes BP4 as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (https://doi.org/10.1016/j.gim.2021.09.012). The supporting evidence is as follows: BP4 - REVEL = 0.325. It is below 0.5, splicing evaluation needed. Functional data on splicing not available. A) variant not on limits. B) does not create AG or GT Variant is not predicted to alter splicing
Met criteria codes
BP4
BP4 - REVEL = 0.325. It is below 0.5, splicing evaluation needed. Functional data on splicing not available. A) variant not on limits. B) does not create AG or GT Variant is not predicted to alter splicing
Not Met criteria codes
BP5
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM2
PM2 - PopMax MAF = 0.001053 (0.11%) in East-Asian European exomes/genomes (gnomAD v2.1.1).
PM5
2 other variants in the same codon but both are classified as VUS per ClinGen LDLR VCEP guidelines
PS4
MAF = 0.105% in East Asians
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.